Research interests include Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, and Protein Degradation and Inhibitors.
Randomized, multi-center study of carfilzomib, lenalidomide, and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM): The ADVANCE clinical trial.
Journal of Clinical Oncology2025cited by 8position: middledoi